ID
25303
Description
Study ID: 101468/197 Clinical Study ID: SKF-101468/197 Study Title:An open study to compare the PK and tolerability of ropinirole administered as 5 different new formulations with the standard, marketed formulation in healthy volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Restless Legs Syndrome
Keywords
Versions (5)
- 8/31/17 8/31/17 -
- 8/31/17 8/31/17 -
- 9/4/17 9/4/17 -
- 9/4/17 9/4/17 -
- 9/11/17 9/11/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
August 31, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
drug screening and alcohol test - compare the PK and tolerability of ropinirole administered as 5 new formulations with the standard, marketed formulation 101468/197
drug screening and alcohol test - compare the PK and tolerability of ropinirole administered as 5 new formulations with the standard, marketed formulation 101468/197
Similar models
drug screening and alcohol test - compare the PK and tolerability of ropinirole administered as 5 new formulations with the standard, marketed formulation 101468/197
C0456984 (UMLS CUI [1,2])
C0456984 (UMLS CUI [1,2])
C0202306 (UMLS CUI [1,2])